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Toxic effects due to acute exposure to copper
are infrequent. Exposure to copper results
almost exclusively from food and water intake
(1–7). The copper content of foods and
drinking water is quite variable. Although the
copper content in water from public supplies
is generally low, higher levels have been
reported in water obtained from some private
wells (8,9). Copper is present in drinking
water as ionizable copper (mostly divalent)
and as copper complexed with organic and
inorganic ligands (10). Some of these com-
plexes are insoluble and are therefore not
likely to be bioavailable or responsible for the
biological effects of copper. 
Intake of drinking water or beverages
with elevated copper concentrations can
induce acute gastrointestinal symptoms,
such as epigastric pain, nausea, vomiting,
and diarrhea (11). However, copper concen-
trations at which these symptoms appear and
the scope of responses observed are not clear
(11). For this reason, the threshold for gas-
trointestinal symptoms of copper in drinking
water has not been precisely established in
controlled prospective studies. In a recent
publication, we established that copper con-
centrations ≥ 3 mg/L, as copper sulfate, in
drinking water produce a signiﬁcant increase
in gastrointestinal symptoms but not in diar-
rhea (12). Because copper sulfate is highly
soluble in water (readily ionizing to produce
Cu2+), it is therefore possible that gastroin-
testinal symptoms could be related to the
concentration of dissolved copper (Cu2+).
The aim of this study was to determine
whether total copper or soluble copper con-
centration is associated with gastrointestinal
signs and symptoms.
Materials and Methods
This study was randomized to copper expo-
sure, blinded to the volunteers and supervi-
sor, and was prospective in nature. The
participants included 45 healthy, adult
women (18–55 years of age), who worked at
home throughout the day and who were nei-
ther pregnant nor lactating. They lived in
urban Santiago, Chile, in a neighborhood
constructed 16 years ago. Houses shared
similar characteristics, and all had copper
piping systems. Volunteers were reimbursed
for the expenses they incurred to attend our
facilities and for the monies they did not
earn on the days of study. Volunteers were
randomized into three groups (15 subjects
each) based on the sequence of soluble/insol-
uble copper salt that they received following
a Latin square design (Figure 1). The differ-
ent proportions of copper sulfate (soluble) to
copper oxide (insoluble) were 0:5, 1:4, 2:3,
3:2, and 5:0 mg/L. The total study duration
was 9 weeks, which was divided into ﬁve 1-
week study periods, with a 1-week break in
between. The blinded nature of the study
assured that subjects did not know exactly
what soluble copper concentration they were
receiving. The Latin square experimental
design was used to control for potential time
effects (e.g., becoming accustomed to the
water) and confounding variables such as
menstrual period, alcohol consumption, and
food intolerance.
All participants received oral information
about the objective and procedures of the
study during an introductory meeting to
which they were invited by means of local
advertisements. Those who decided to par-
ticipate signed an informed consent form
before they were included in the study. The
protocol was approved by the Ethics in
Human Research Committee of the Institute
of Nutrition and Food Technology of the
University of Chile.
For every week of each study period the
subjects received seven dark-polypropylene
flasks filled with a solution to add to their
home drinking water. Every morning each
subject mixed the test solution contained in
the ﬂasks provided with tap water in a gradu-
ated polypropylene container 2 L in size.
Subjects were instructed to vigorously shake
the container before drinking the water or
consuming infusions and beverages right
after they are prepared. At the end of each
day any remaining water in the container was
discarded. At this time, every subject also reg-
istered on an ad-hoc form the amount of
water ingested, the amount left in the con-
tainer, and any symptoms experienced dur-
ing the day (nausea, vomiting, abdominal
pain or cramps, diarrhea, headache, joint
pain, backache, change of appetite, etc).
During the nonstudy periods (break weeks)
the subjects were also asked to record daily
any gastrointestinal symptoms on a form.
Twice a week a field worker monitored
the in-home preparation of the test water,
evaluated the morbidity reported since the
last site visit, and supervised the completion
of questionnaires. Subjects who developed
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The aim of this study was to determine whether total copper or soluble copper concentration is
associated with gastrointestinal signs and symptoms. Forty-five healthy adult women (18–55
years of age), living in Santiago, Chile, ingested tap water with 5 mg/L of copper containing dif-
ferent ratios of soluble copper (copper sulfate) and insoluble copper (copper oxide) over a 9-week
period. Three randomized sequences of the different copper ratios (0:5, 1:4, 2:3, 3:2, and 5:0
mg/L) were followed. Subjects recorded their water consumption and gastrointestinal symptoms
daily on a special form. Mean water consumption was similar among groups. Serum copper lev-
els, ceruloplasmin, and activities of liver enzymes were within normal limits. No differences were
detected between the means of biochemical parameters at the beginning and at the end of the
study. Twenty subjects presented gastrointestinal disturbances at least once during the study, 9
suffered diarrhea (with or without abdominal pain and vomiting), and the other 11 subjects
reported abdominal pain, nausea, or vomiting. No differences were found in incidence of abdomi-
nal pain, nausea, vomiting, and diarrhea regardless of the ratio of copper sulfate to copper oxide.
In conclusion, both copper sulfate (a soluble compound) and copper oxide (an insoluble com-
pound) have comparable effects on the induction of gastrointestinal manifestations, implying that
similar levels of ionic copper were present in the stomach. Key words: drinking water, gastroin-
testinal symptoms, insoluble copper, ionic copper. Environ Health Perspect 109:949–952 (2001).
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instructed to stop consumption of the test
water for the next 2 days. If the symptoms
disappeared, the individual resumed con-
sumption of the test water. If the symptoms
reappeared, the subject was instructed to
stop drinking the test water until the next
study period began. 
Once a week, the actual copper concen-
tration and pH (HANNA Instruments,
Model Checker 1, Woonsocket, RI, USA) of
water prepared by the subjects in their homes
were determined by examination of samples
obtained by ﬁeld workers during unexpected
home visits. Soluble copper was measured
directly by absorption atomic spectrophotom-
etry in a sample of centrifuged water (Perkin
Elmer Model 2280, Norwalk, CT, USA; sen-
sitivity = 0.01 µg/mL and variability = < 3%);
total copper was measured in the samples,
previously mixed with HCl 1 N in a propor-
tion of 1:1. The insoluble copper was deﬁned
as the total copper minus soluble copper. The
concentrations of ionic copper (Cu2+) in the
different CuO/CuSO4 mixtures were deter-
mined under simulated gastric conditions
(37.5°C and pH 2) using a cupric electrode
(Orion, model 9629 ion plus series, Orion
Research, Inc., Beverly, MA, USA).
The average maximum ion concentra-
tions in drinking water of the city of Santiago
are as follows: sulfate (280 mg/L), calcium
(169 mg/L,), sodium (46 mg/L), chloride (68
mg/L), magnesium (12 mg/L), ﬂuoride (0.6
mg/L), and copper (0.03 mg/L) (13).
To evaluate changes in copper nutritional
status associated with the copper administered
during the study, we obtained blood samples
1 week before the beginning of the study and
again at the end of the protocol. Serum cop-
per was measured by atomic absorption
spectrophotometry and ceruloplasmin by
radial immunodiffusion (The Binding Site,
Birminghan, UK); aspartate-aminotransferase
(ASAT), alanine-aminotransferase (ALAT),
and L-γ -glutamyl transferase (GGT) were
measured by enzymatic assays (Boehringer,
Mannheim, Germany). Hemoglobin (Hb)
was also measured (Coulter Electronic Inc.,
Hialeah, FL, USA). 
Geometric means for ASAT, ALAT, and
GGT were calculated because their distribu-
tions were non-Gaussian. 
Statistical analyses were carried out using
the Student’s t-test for dependent samples,
the analysis of variance and Sheffé’s multiple
comparison test, the chi-square test, or
Fisher’s Exact test.
Results
There were no signiﬁcant differences in age,
weight, and height of the subjects among the
groups. The means and SDs for all the sub-
jects were 25.6 ± 5.1 years, 62.7 ± 9.9 kg, and
1.60 ± 0.06 m, respectively. 
Serum copper level activities of liver
enzymes (ASAT, ALAT, and GGT) and
ceruloplasmin were within the normal limits,
but seven women were anemic (Hb < 120
g/L). No differences were detected between
the means of biochemical parameters at the
beginning and at the end of the study
(Table 1).
The copper content of tap water was
< 0.1 mg/L and therefore was not considered
to be a significant source of copper. Mean
water consumption was similar among
groups (Figure 2). Seventy percent of subjects
consumed > 1.0 L daily, despite the level of
copper in the water, and only 3% ingested
< 0.5 L water/day. Fluid intake showed little
individual differences throughout the study
(up to ± 0.3 L/day). Although not recorded
in detail in this protocol, in all our previous
studies among this type of population, one-
third of total daily water intake is as plain
water, one-third as home-prepared flavored
drinks, and one-third as tea or coffee. Figure
3 shows the mean of soluble and nonsoluble
copper measured in the samples of water pre-
pared by the subjects. When the water was
prepared with 0:5,1:4, 2:3, 3:2, and 5:0
ratios of copper sulfate:copper oxide (mg:mg
per L), the means and SDs of soluble copper
measured from the samples were 0.1 ± 0.2,
0.9 ± 0.5, 1.8 ± 0.6, 2.7 ± 0.6, and 4.7 ± 0.8
mg/L, respectively. For total copper the
means and SDs were 4.7 ± 1.4, 5.3 ± 1.6, 4.7
± 1.9, 5.2 ± 0.6, and 5.1 ± 0.6 mg/L, respec-
tively (F = 2.03; not signiﬁcant). 
When copper was measured at simulated
gastric conditions, a high proportion of cop-
per was ionic (Cu2+), regardless of the pro-
portion of salts present in the drinking water.
Percentages of Cu2+ ranged from 90% to
100% for all of the copper solutions studied. 
Table 2 summarizes the symptomatology
observed by concentration of soluble copper
in drinking water. Twenty subjects presented
gastrointestinal disturbances at least once
during the study, 9 suffered diarrhea (with or
without abdominal pain and vomiting), and
the other 11 subjects reported abdominal
pain, nausea, or vomiting. Expressing results
by the ratio copper sulfate:copper oxide
ingested oxide (0:5, 1:4, 2:3, 3:2, and 5:0
mg:milligrams per liter) 5, 3, 3, 2, and 6
episodes of gastrointestinal symptoms
(excluding diarrhea) were reported, respec-
tively (χ 2 = 3.03, not signiﬁcant). No differ-
ences were found in incidence of diarrhea
depending on the ratio of copper sulfate to
copper oxide (χ 2 =3.89; not significant).
Seven of the 10 episodes of diarrhea detected
occurred in the ﬁrst half of the study period.
This was not the case with nausea and
abdominal pain, which were homogeneously
distributed throughout the study period.
Contrasting the symptoms reported
when the subjects ingested 5 mg/L of added
copper (in different proportion of copper
sulfate:copper oxide) with those reported by
the same subjects during the period when
they ingested plain tap water (break weeks),
the incidence of total gastrointestinal symp-
toms with 5 mg Cu/L was significantly
higher (p < 0.01; Table 3).
Discussion
Copper ingested from food and water is
rarely harmful to humans because the con-
tent of ionic copper is relatively low. Food is
the principal source of copper for humans
unless copper-contaminated water is con-
sumed. The copper content of potable water
is low; however, acidic and hard water, espe-
cially if it is conducted by newly installed
copper pipes, may be highly corrosive, thus
increasing the copper concentration of
water. Stagnation is another factor that will
increase copper content of water, and should
be considered when establishing sampling
procedures. Copper can produce gastroin-
testinal symptoms by irritating the gut
mucosa and/or altering the microbial ﬂora of
the colon. Animal studies have shown that
vomiting induced by copper is mediated by
serotonine gastric receptors. In addition,
copper has a direct effect on gastric mucosa
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Table 1. Copper nutrition status, liver enzymes, and hemoglobin concentrations at the beginning and at
the end of the study.
Baseline Final Change (%) p-Valuea
Serum copper (µg/dL) 129 ± 29 125 ± 32 –2.6 0.125
Ceruloplasmin (mg/dL) 40.4 ± 10.7 40.2 ± 10.8 –0.5 0.887
ASAT, U/Lb (range) 8.7 (13.3–5.6) 9.8 (14.4–6.6) 12.9 0.060
ALAT, U/Lb (range) 7.1 (12.9–3.9) 8.1 (16.1–4.1) 14.8 0.146
GGT, U/Lb (range) 6.1 (14.2–2.6) 4.9 (11.0–2.2) –19.6 0.089
Hb (g/L) 143 ± 15 144 ± 11 1.1 0.249
aAll p-values were nonsigniﬁcant (t-test). bGeometric mean and range ±1 standard deviation. 
Figure 1. Latin square design of study. Forty-five
women were assigned to three groups of 15 sub-
jects each (A, B, or C) with copper ratio patterns
(mg copper sulfate:mg copper oxide).
123456789
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Drinking water (mg added copper/L)
0:5 1:4 2:3 3:2 5:0
3:2 5:0 0:5 1:4 2:3
5:0 3:2 2:3 1:4 0:5
Weeks of follow-upnerve endings of the parasymphatic nervous
system (14–16). Direct stimulation of the
vomiting center in the central nervous sys-
tem by absorbed copper ions may occur with
acute ingestion of highly soluble copper salts
(17), suggesting that the emetic effect is a
protective response. 
We, as well as others, have demonstrated
that copper in drinking water may cause gas-
trointestinal disturbances if the concentra-
tion is sufficiently high (18–21). However,
most published studies have serious method-
ological problems, such as uncertainty of the
copper concentration in the beverage or
drinking water at the time of the episode of
gastrointestinal symptoms, presence of con-
founding variables such as alcohol or nitrate
intake associated with the episodes, and lack
of information on the microbiological qual-
ity of drinking water or beverages that were
involved in the episodes (10). In our recent
study using a randomized, controlled design,
we demonstrated a significant increase in
nausea, abdominal pain, and vomiting in
adult women receiving water with ≥ 3 mg
Cu/L (11). In this previous study volunteers
ingested copper salts only as plain water.
Study subjects received a highly ionizable
copper compound (CuSO4) with high water
solubility (316 g/L). 
The present study was designed to
address the following question: Can insolu-
ble copper oxide induce gastrointestinal
symptoms at the equivalent copper content
of a copper sulfate solution? As representative
of an insoluble compound, we chose cupric
oxide (CuO) because it is the most common
copper form added to vitamin and mineral
supplements. The total concentration of cop-
per was ﬁxed at 5 mg/L because at lower cop-
per concentrations previous studies suggested
that gastrointestinal complaints might be
infrequent, making it potentially difﬁcult to
demonstrate statistically significant differ-
ences of the end points deﬁned. Presumably
the intragastric concentration of ionic copper
varied depending on the sum of CuSO4 and
the proportion of copper oxide that became
ionized in the acid gastric environment.
Comparing the gastrointestinal symp-
toms reported while ingesting plain or cop-
per-added water, ingestion of water with 5
mg/L of added copper, resulted in a 4-fold
increase in reported gastrointestinal symp-
toms (nausea, abdominal pain, vomiting,
and diarrhea). The incidence of gastrointesti-
nal symptoms, however, was not signifi-
cantly different among the individuals
receiving the different ratios of soluble/insol-
uble copper salts, thus disproving the
hypothesis that mainly soluble copper com-
pounds would be responsible for acute gas-
trointestinal symptoms. On the contrary, the
similar prevalence of symptoms observed
among the groups suggests that copper oxide
is rapidly solubilized by the low intragastric
pH. This proposition was supported by our
in vitro studies, which demonstrated that at
pH 2 > 90% of copper provided as copper
oxide was ionized within 5 min. 
Classic parameters of copper status and
liver function did not change signiﬁcantly. As
in previous studies using a control exposure
to 5 mg Cu/L, none of the subjects presented
liver function tests beyond the normal range.
Because of the borderline increase (p = 0.06)
observed on ASAT levels, case-by-case analy-
sis was done; this showed that in none of the
cases were the changes detected on enzyme
activity clinically signiﬁcant. 
Six out of the 12 total episodes of diarrhea
observed in the study occurred during the ini-
tial 7 days of this 2 month study, suggesting
that copper tolerance develops over time. This
is in agreement with our previous finding
(when copper sulfate was tested at 1, 3, 5
mg/L as sulfate) of a time effect in diarrhea
prevalence, independent of dose. The preva-
lence of diarrhea decreased over the initial 2
weeks (11). No time effect was observed for
nausea, abdominal pain, and vomiting. 
If we extrapolate our ﬁndings to the usual
form of copper exposure (i.e., copper-conta-
minated water consumed with food), we
should consider that food would bind the
copper ions, preventing gastrointestinal
symptoms. Thus consumption of the plain
water and not copper with food would have a
higher risk of triggering acute gastrointestinal
manifestations. This is supported by a recent
study in which we compared the incidence of
nausea in subjects receiving beverages with
graded copper concentration as plain water
or as an orange-ﬂavored drink (22). The inci-
dence of nausea dropped from 54% (while
taking copper in plain water) to 18% when
subjects received equivalent copper concen-
trations in the orange-ﬂavored beverage. 
Our current study design does not permit
a detailed examination of similar variables,
such as consuming the water in the form of
coffee or other forms where the copper may
be absorbed in a third element (e.g., coffee
grounds). Our study is also limited in that we
did not control for the timing of water con-
sumption. That is, we did not ask the sub-
jects to record what times they consumed the
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Figure 2. Mean water intake (L/day) per study
groups.
Figure 3. Mean of soluble and nonsoluble copper
measured in water prepared by subjects. The
orange line represents the theoretical soluble cop-
per concentration; the black line and the gray area
represent the mean of total copper concentration
and ± 2 SEM.
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Table 2. Effect of copper on incidence of gastrointestinal symptoms (episodes per week in 45 women).
Copper sulfate:copper oxide (mg/L) 
0:5 1:4 2:3 3:2 5:0
Diarrhea, vomiting, and abdominal pain 0 0 0 0 0
Diarrhea and vomiting  0 0 0 0 0
Diarrhea and abdominal pain 1 2 0 1 2
Diarrhea only 2 1 0 0 0
Vomiting and abdominal pain 0 0 0 0 0
Abdominal pain only 1 0 3 1 0
Vomiting only 1 2 0 0 1
Nausea only 3 1 0 1 5
Episodes of diarrhea 3 3 0 1 2
Gastrointestinal symptomsa 53 326
Total 8 6 3 3 8
aDiarrhea is not included.
Table 3. Gastrointestinal (GI) morbidity (mean episodes per subject per week) by study periods in 45 subjects.
Periods with Cu  Washout periods, Wilcoxon
Morbidity added to water no Cu added matched pairs test
Diarrhea (range) 0.04 (0–0.20) 0.01 (0–0.25) < 0.02
GI symptoms (range) 0.08 (0–0.60) 0.02 (0–0.25) < 0.02
Total of GI symptoms (range) 0.12 (0–0.60) 0.03 (0–0.25) < 0.001water nor if they consumed the water alone
or with a meal. It is possible that subjects
may have consumed the water with meals
consciously or subconsciously to reduce gas-
trointestinal effects.
The aim of this study was to determine
whether total copper concentration or the
proportion of soluble copper was associated
with gastrointestinal symptoms. We conclude
that both copper sulfate (a soluble com-
pound) and copper oxide (an insoluble com-
pound) have comparable effects, implying
that the ionic copper present in the stomach
is responsible for the induction of gastroin-
testinal manifestations. People with achloridia
or the elderly may be at increased risk for cop-
per deﬁciency, as is the case for subjects con-
suming antacids, because copper absorption
requires that the metal be in the ionized form.
Further research is also needed to elucidate if
less soluble compounds such as malachite
[Cu2(OH)2CO3] found in drinking water can
also elicit gastrointestinal symptoms. 
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